Logo image of TRS

TRIMAS CORP (TRS) Stock Fundamental Analysis

NASDAQ:TRS - Nasdaq - US8962152091 - Common Stock - Currency: USD

30.11  +0.04 (+0.13%)

After market: 30.11 0 (0%)

Fundamental Rating

4

TRS gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 22 industry peers in the Containers & Packaging industry. While TRS seems to be doing ok healthwise, there are quite some concerns on its profitability. While showing a medium growth rate, TRS is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

TRS had positive earnings in the past year.
In the past year TRS had a positive cash flow from operations.
Of the past 5 years TRS 4 years were profitable.
In the past 5 years TRS always reported a positive cash flow from operatings.
TRS Yearly Net Income VS EBIT VS OCF VS FCFTRS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

1.2 Ratios

TRS's Return On Assets of 2.26% is in line compared to the rest of the industry. TRS outperforms 50.00% of its industry peers.
TRS has a Return On Equity (4.59%) which is comparable to the rest of the industry.
With a Return On Invested Capital value of 3.60%, TRS is not doing good in the industry: 72.73% of the companies in the same industry are doing better.
TRS had an Average Return On Invested Capital over the past 3 years of 4.55%. This is below the industry average of 7.58%.
Industry RankSector Rank
ROA 2.26%
ROE 4.59%
ROIC 3.6%
ROA(3y)3.3%
ROA(5y)1.52%
ROE(3y)6.57%
ROE(5y)3.03%
ROIC(3y)4.55%
ROIC(5y)4.78%
TRS Yearly ROA, ROE, ROICTRS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

TRS's Profit Margin of 3.36% is in line compared to the rest of the industry. TRS outperforms 50.00% of its industry peers.
In the last couple of years the Profit Margin of TRS has declined.
Looking at the Operating Margin, with a value of 5.87%, TRS is doing worse than 68.18% of the companies in the same industry.
TRS's Operating Margin has declined in the last couple of years.
The Gross Margin of TRS (21.74%) is comparable to the rest of the industry.
TRS's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 5.87%
PM (TTM) 3.36%
GM 21.74%
OM growth 3Y-22.8%
OM growth 5Y-16.54%
PM growth 3Y-26.81%
PM growth 5Y-28.08%
GM growth 3Y-5.16%
GM growth 5Y-4.21%
TRS Yearly Profit, Operating, Gross MarginsTRS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

6

2. Health

2.1 Basic Checks

TRS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
TRS has less shares outstanding than it did 1 year ago.
TRS has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, TRS has a worse debt to assets ratio.
TRS Yearly Shares OutstandingTRS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
TRS Yearly Total Debt VS Total AssetsTRS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

TRS has an Altman-Z score of 2.13. This is not the best score and indicates that TRS is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of TRS (2.13) is better than 68.18% of its industry peers.
TRS has a debt to FCF ratio of 16.75. This is a negative value and a sign of low solvency as TRS would need 16.75 years to pay back of all of its debts.
TRS has a Debt to FCF ratio of 16.75. This is comparable to the rest of the industry: TRS outperforms 50.00% of its industry peers.
A Debt/Equity ratio of 0.63 indicates that TRS is somewhat dependend on debt financing.
TRS's Debt to Equity ratio of 0.63 is amongst the best of the industry. TRS outperforms 81.82% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 16.75
Altman-Z 2.13
ROIC/WACC0.47
WACC7.71%
TRS Yearly LT Debt VS Equity VS FCFTRS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.3 Liquidity

A Current Ratio of 2.82 indicates that TRS has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.82, TRS belongs to the top of the industry, outperforming 95.45% of the companies in the same industry.
TRS has a Quick Ratio of 1.49. This is a normal value and indicates that TRS is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.49, TRS belongs to the top of the industry, outperforming 90.91% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.82
Quick Ratio 1.49
TRS Yearly Current Assets VS Current LiabilitesTRS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

4

3. Growth

3.1 Past

TRS shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -3.31%.
The Earnings Per Share has been decreasing by -0.59% on average over the past years.
The Revenue has been growing slightly by 3.80% in the past year.
The Revenue has been growing slightly by 5.04% on average over the past years.
EPS 1Y (TTM)-3.31%
EPS 3Y-9.51%
EPS 5Y-0.59%
EPS Q2Q%24.32%
Revenue 1Y (TTM)3.8%
Revenue growth 3Y2.57%
Revenue growth 5Y5.04%
Sales Q2Q%6.42%

3.2 Future

The Earnings Per Share is expected to grow by 14.37% on average over the next years. This is quite good.
Based on estimates for the next years, TRS will show a small growth in Revenue. The Revenue will grow by 5.51% on average per year.
EPS Next Y11.07%
EPS Next 2Y14.37%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year5.52%
Revenue Next 2Y5.51%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
TRS Yearly Revenue VS EstimatesTRS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B
TRS Yearly EPS VS EstimatesTRS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 17.21, which indicates a rather expensive current valuation of TRS.
TRS's Price/Earnings ratio is a bit cheaper when compared to the industry. TRS is cheaper than 63.64% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.30. TRS is valued slightly cheaper when compared to this.
With a Price/Forward Earnings ratio of 13.87, TRS is valued correctly.
TRS's Price/Forward Earnings is on the same level as the industry average.
The average S&P500 Price/Forward Earnings ratio is at 21.76. TRS is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 17.21
Fwd PE 13.87
TRS Price Earnings VS Forward Price EarningsTRS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, TRS is valued a bit more expensive than the industry average as 63.64% of the companies are valued more cheaply.
The rest of the industry has a similar Price/Free Cash Flow ratio as TRS.
Industry RankSector Rank
P/FCF 47.06
EV/EBITDA 13.58
TRS Per share dataTRS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as TRS's earnings are expected to grow with 14.37% in the coming years.
PEG (NY)1.55
PEG (5Y)N/A
EPS Next 2Y14.37%
EPS Next 3YN/A

3

5. Dividend

5.1 Amount

TRS has a yearly dividend return of 0.53%, which is pretty low.
TRS's Dividend Yield is slightly below the industry average, which is at 2.90.
Compared to an average S&P500 Dividend Yield of 2.37, TRS's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.53%

5.2 History

TRS has been paying a dividend for over 5 years, so it has already some track record.
TRS has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years3
TRS Yearly Dividends per shareTRS Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 0.05 0.1 0.15

5.3 Sustainability

20.87% of the earnings are spent on dividend by TRS. This is a low number and sustainable payout ratio.
DP20.87%
EPS Next 2Y14.37%
EPS Next 3YN/A
TRS Yearly Income VS Free CF VS DividendTRS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M
TRS Dividend Payout.TRS Dividend Payout, showing the Payout Ratio.TRS Dividend Payout.PayoutRetained Earnings

TRIMAS CORP

NASDAQ:TRS (7/11/2025, 8:00:02 PM)

After market: 30.11 0 (0%)

30.11

+0.04 (+0.13%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryContainers & Packaging
Earnings (Last)04-29 2025-04-29/bmo
Earnings (Next)07-24 2025-07-24/bmo
Inst Owners103.2%
Inst Owner Change-0.08%
Ins Owners6.25%
Ins Owner Change5.03%
Market Cap1.22B
Analysts76.67
Price Target34.83 (15.68%)
Short Float %9.68%
Short Ratio6.57
Dividend
Industry RankSector Rank
Dividend Yield 0.53%
Yearly Dividend0.16
Dividend Growth(5Y)N/A
DP20.87%
Div Incr Years0
Div Non Decr Years3
Ex-Date05-06 2025-05-06 (0.04)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.63%
Min EPS beat(2)-10.46%
Max EPS beat(2)13.72%
EPS beat(4)1
Avg EPS beat(4)-9.06%
Min EPS beat(4)-20.05%
Max EPS beat(4)13.72%
EPS beat(8)3
Avg EPS beat(8)-7.05%
EPS beat(12)4
Avg EPS beat(12)-7.04%
EPS beat(16)7
Avg EPS beat(16)-4.68%
Revenue beat(2)1
Avg Revenue beat(2)0.72%
Min Revenue beat(2)-0.21%
Max Revenue beat(2)1.64%
Revenue beat(4)1
Avg Revenue beat(4)-0.97%
Min Revenue beat(4)-5.11%
Max Revenue beat(4)1.64%
Revenue beat(8)2
Avg Revenue beat(8)-4.16%
Revenue beat(12)3
Avg Revenue beat(12)-4.14%
Revenue beat(16)3
Avg Revenue beat(16)-3.69%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)1.37%
EPS NY rev (1m)0%
EPS NY rev (3m)2.99%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.17%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.03%
Valuation
Industry RankSector Rank
PE 17.21
Fwd PE 13.87
P/S 1.3
P/FCF 47.06
P/OCF 15.97
P/B 1.78
P/tB 8.37
EV/EBITDA 13.58
EPS(TTM)1.75
EY5.81%
EPS(NY)2.17
Fwd EY7.21%
FCF(TTM)0.64
FCFY2.13%
OCF(TTM)1.89
OCFY6.26%
SpS23.11
BVpS16.89
TBVpS3.6
PEG (NY)1.55
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.26%
ROE 4.59%
ROCE 4.49%
ROIC 3.6%
ROICexc 3.7%
ROICexgc 6.75%
OM 5.87%
PM (TTM) 3.36%
GM 21.74%
FCFM 2.77%
ROA(3y)3.3%
ROA(5y)1.52%
ROE(3y)6.57%
ROE(5y)3.03%
ROIC(3y)4.55%
ROIC(5y)4.78%
ROICexc(3y)4.82%
ROICexc(5y)5.17%
ROICexgc(3y)9.3%
ROICexgc(5y)10.22%
ROCE(3y)5.66%
ROCE(5y)5.96%
ROICexcg growth 3Y-26.13%
ROICexcg growth 5Y-19.63%
ROICexc growth 3Y-23.76%
ROICexc growth 5Y-16.4%
OM growth 3Y-22.8%
OM growth 5Y-16.54%
PM growth 3Y-26.81%
PM growth 5Y-28.08%
GM growth 3Y-5.16%
GM growth 5Y-4.21%
F-Score7
Asset Turnover0.67
Health
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 16.75
Debt/EBITDA 3.64
Cap/Depr 78.45%
Cap/Sales 5.39%
Interest Coverage 2.9
Cash Conversion 64.03%
Profit Quality 82.49%
Current Ratio 2.82
Quick Ratio 1.49
Altman-Z 2.13
F-Score7
WACC7.71%
ROIC/WACC0.47
Cap/Depr(3y)86.35%
Cap/Depr(5y)84.94%
Cap/Sales(3y)5.59%
Cap/Sales(5y)5.46%
Profit Quality(3y)59.07%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-3.31%
EPS 3Y-9.51%
EPS 5Y-0.59%
EPS Q2Q%24.32%
EPS Next Y11.07%
EPS Next 2Y14.37%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)3.8%
Revenue growth 3Y2.57%
Revenue growth 5Y5.04%
Sales Q2Q%6.42%
Revenue Next Year5.52%
Revenue Next 2Y5.51%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-23.63%
EBIT growth 3Y-20.81%
EBIT growth 5Y-12.34%
EBIT Next Year42.4%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-6.1%
FCF growth 3Y-47.6%
FCF growth 5Y-22.52%
OCF growth 1Y0.08%
OCF growth 3Y-21.96%
OCF growth 5Y-3.34%